o None
Entity Type
0001519177
Health Directory Inc.
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 SOLLENSYS CORP.
Jurisdiction of Incorporation/Organization
NEVADA
 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed  



2. Principal Place of Business and Contact Information
Name of Issuer  
 SOLLENSYS CORP.  
Street Address 1 Street Address 2
 2570 N. FIRST STREET  SUITE 200
City State/Province/Country ZIP/Postal Code Phone No. of Issuer
 SAN JOSE  CALIFORNIA  95131  321-676-8173 



3. Related Persons
Last Name First Name Middle Name
Beavers Donald
Street Address 1 Street Address 2
2479 Palm Bay Road NE Suite 2
City State/Province/Country ZIP/Postal Code
Palm Bay FLORIDA 32905
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 


4. Industry Group
o Agriculture   Health Care o Retailing
  Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance   Technology
  o Insurance   o Hospitals & Physicians   o Computers
  o Investing   o Pharmaceuticals   o Telecommunications
  o Investment Banking   o Other Health Care   o Other Technology
  o Pooled Investment Fund

        Travel
  o Other Banking & Financial Services o Manufacturing   o Airlines & Airports
  Real Estate   o Lodging & Conventions
  o Commercial   o Tourism & Travel Services
  o Construction   o Other Travel
  o REITS & Finance x Other
  o Residential  
  o Other Real Estate  
o Business Services  
  Energy  
  o Coal Mining  
  o Electric Utilities  
  o Energy Conservation  
  o Environmental Services  
  o Oil & Gas  
  o Other Energy  


5. Issuer Size
Revenue Range Aggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale  2020-11-20 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities o Option, Warrant or Other Right to Acquire Another Security
o Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
   


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? x Yes o No
 
Clarification of Response (if Necessary)  
 The shares were issued by Sollensys Corp. in connection with a reorganization under Section 368(a)(1)(B) of the Internal Revenue Code of 1986, as amended, in exchange for shares of Eagle Lake Laboratories, Inc. received by Sollensys Corp.

11. Minimum Investment
Minimum investment accepted from any outside investor $ 0 USD

12. Sales Compensation
Recipient Recipient CRD Number x None
 None   
(Associated) Broker or Dealer x None (Associated) Broker or Dealer CRD Number x None
     
Street Address 1 Street Address 2
 None   
City State/Province/Country ZIP/Postal Code
 None  Unknown  00000
State(s) of Solicitation o All States x Foreign/Non-US
 ARIZONA
 CALIFORNIA
 COLORADO
 FLORIDA
 GEORGIA
 KENTUCKY
 NORTH CAROLINA
 NEW HAMPSHIRE
 NEVADA
 TEXAS
 VIRGINIA
 

 



13. Offering and Sales Amounts
Total Offering Amount $ 0 USD o Indefinite
Total Amount Sold $ 0 USD  
Total Remaining to be Sold $ 0 USD o Indefinite
 
Clarification of Response (if Necessary)
 The shares were issued by Sollensys Corp. in connection with a reorganization under Section 368(a)(1)(B) of the Internal Revenue Code of 1986, as amended, in exchange for shares of Eagle Lake Laboratories, Inc. received by Sollensys Corp.


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 116


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions $ 0 USD x Estimate
Finders' Fees $ 0 USD x Estimate
 
Clarification of Response (if Necessary)
  


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
  $ 0 USD x
Sollensys (PK) (USOTC:SOLS)
Historical Stock Chart
From Jun 2021 to Jul 2021 Click Here for more Sollensys (PK) Charts.
Sollensys (PK) (USOTC:SOLS)
Historical Stock Chart
From Jul 2020 to Jul 2021 Click Here for more Sollensys (PK) Charts.